ABVC BioPharma Investor Relations Material
Latest events
Q1 2025
29 Apr, 2025
Q4 2024
15 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ABVC BioPharma Inc
Access all reports
ABVC BioPharma Inc. is a U.S.-based biotechnology company engaged in the research, development, and commercialization of pharmaceutical and medical device products. The company focuses on advancing drug candidates and therapies in areas such as oncology, central nervous system disorders, and ophthalmology. ABVC BioPharma leverages partnerships with research institutions and healthcare organizations to develop innovative treatment solutions. ABVC BioPharma Inc. is headquartered in Fremont, California, and its shares are listed on the Nasdaq Stock Market (NASDAQ).
Key slides for ABVC BioPharma Inc
Corporate Presentation
ABVC BioPharma Inc
Corporate Presentation
ABVC BioPharma Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ABVC
Country
🇺🇸 United States